The legacy success of sildenafil has undeniably influenced the pharmaceutical landscape. However, putting money in companies heavily reliant on biosimilars and the waning patent exclusivity surrounding this iconic medication presents a notable degree of peril . While established pharma firms might still profit from related offerings, the long-term

A thorough industry assessment is critical for grasping the current trends at play. This exploration delves into key aspects influencing the contested environment, from emerging technologies and changing consumer demands to regulatory obstacles and financial uncertainties. We’ll evaluate the general outlook, including likely growth areas, dangers